Search Results 31-40 of 16836 for Goserelin

1. Fezolinetant (oral route) - Side effects & dosage - Mayo Clinic

   Description. Fezolinetant is used to reduce moderate to severe symptoms of menopause, including feelings of warmth in the face, neck, and chest, ...

2. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

   ... goserelin or leuprolide to be used concomitantly with alpelisib in combination with fulvestrant or letrozole. Patient is postmenopausal woman defined as ...

3. Givosiran (subcutaneous route) - Side effects & uses - Mayo Clinic

   Givosiran injection is used to treat patients with acute hepatic porphyria. This medicine is to be given only by or under the direct supervision of your doctor.

4. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

   Women who are premenopausal must agree to begin or continue an LHRH agonist (goserelin preferred). ... Known hypersensitivity to palbociclib, letrozole, ...

5. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

   No prior hormonal therapy, such as luteinizing hormone-releasing hormone (LHRH) agonists (e.g., leuprolide, goserelin, buserelin, triptorelin) or LHRH ...

6. Breast Cancer Clinical Trials - Mayo Clinic Research

   Hormone therapy using tamoxifen citrate, goserelin acetate, leuprolide acetate, anastrozole, letrozole, or exemestane, may fight breast cancer by lowering the ...

7. Glyburide (oral route) - Side effects & dosage - Mayo Clinic

   Description. Glyburide is used to treat high blood sugar levels caused by a type of diabetes mellitus (sugar diabetes) called type 2 diabetes.

8. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

   Note: Ovarian radiation or treatment with a gonadotropin releasing hormone agonist (GnRHas e.g. goserelin acetate) is not permitted for induction of ovarian ...

9. Exemestane (oral route) - Side effects & dosage - Mayo Clinic

   It is usually used in women who have already received a cancer medication called tamoxifen. Many breast cancer tumors grow in response to estrogen. Exemestane ...

10. Toremifene (oral route) - Side effects & dosage - Mayo Clinic

    Many of the breast cancer tumors will grow when estrogen is available in the body. This medicine blocks the effects of the estrogen hormone. As a result, the ...